Get the Stockscreener App
2.99
0.33%
-0.010
After Hours:
2.99
Akoya Biosciences Inc stock is traded at $2.99, with a volume of 440.40K.
It is down -0.33% in the last 24 hours and up +25.63% over the past month.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
See More
Previous Close:
$3.00
Open:
$3.04
24h Volume:
440.40K
Relative Volume:
0.74
Market Cap:
$148.22M
Revenue:
$96.63M
Net Income/Loss:
$-63.32M
P/E Ratio:
-2.0479
EPS:
-1.46
Net Cash Flow:
$-54.55M
1W Performance:
-7.43%
1M Performance:
+25.63%
6M Performance:
+21.05%
1Y Performance:
-39.60%
1-Day Range:
$2.92
$3.10
1-Week Range:
$2.92
$3.21
52-Week Range:
$1.88
$6.31
Akoya Biosciences Inc Stock (AKYA) Company Profile
Name
Akoya Biosciences Inc
Sector
Industry
Phone
855.896.8401
Address
100 CAMPUS DRIVE, MARLBOROUGH
Compare AKYA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AKYA
Akoya Biosciences Inc
|
2.99 | 148.22M | 96.63M | -63.32M | -54.55M | -1.46 |
|
ISRG
Intuitive Surgical Inc
|
580.18 | 206.65B | 8.35B | 2.32B | 586.00M | 6.41 |
|
BDX
Becton Dickinson Co
|
248.49 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
92.32 | 45.66B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
257.65 | 37.85B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
343.91 | 24.95B | 2.88B | 499.60M | 321.60M | 6.74 |
Akoya Biosciences Inc Stock (AKYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-06-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-06-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-06-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-21-24 | Initiated | Craig Hallum | Buy |
| Dec-14-23 | Initiated | Guggenheim | Neutral |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Feb-02-23 | Initiated | UBS | Buy |
| Nov-03-22 | Initiated | CapitalOne | Overweight |
| Oct-06-22 | Initiated | Stephens | Overweight |
| Jun-22-22 | Initiated | BTIG Research | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| May-11-21 | Initiated | Canaccord Genuity | Buy |
| May-11-21 | Initiated | JP Morgan | Overweight |
| May-11-21 | Initiated | Morgan Stanley | Overweight |
| May-11-21 | Initiated | Piper Sandler | Overweight |
View All
Akoya Biosciences Inc Stock (AKYA) Latest News
Major Breakthrough: Akoya's Advanced Diagnostic Tech Gets Manufacturing Powerhouse Backing - StockTitan
Quanterix Nears All-Stock Deal for Akoya Biosciences - MSN
Spatial Proteomics Market Report and Competitive Landscape 2025-2030, with 10X Genomics, Bruker, Fluidigm, Akoya Biosciences, PerkinElmer, Biotechne, S2 Genomics, Seven Bridges Genomics & More - Yahoo Finance
Barclays PLC Buys 30,095 Shares of Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Consensus Rating of “Hold” from Analysts - Defense World
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Jane Street Group LLC Decreases Stock Holdings in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Akoya Biosciences (NASDAQ:AKYA) Cut to Hold at Canaccord Genuity Group - Defense World
Akoya Biosciences (NASDAQ:AKYA) Downgraded by Canaccord Genuity Group to Hold - MarketBeat
Major Player in the Spatial Biology Market Analysis by Type, - openPR
Quanterix merging with Akoya to bolster biomarker portfolio - BioWorld Online
Quanterix announces acquisition of Akoya Biosciences By Investing.com - Investing.com Canada
Quanterix announces acquisition of Akoya Biosciences - Investing.com
Akoya Biosciences (NASDAQ: AKYA) Enters Merger Agreement with Quanterix Corporation - Defense World
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK, ACCD, ESSA, AKYA on Behalf of Shareholders - GlobeNewswire Inc.
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ESSA, AKYA, CCNE, QTRX on Behalf of Shareholders - The Malaysian Reserve
$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the MergerACCD, QTRX, AKYA, ESSA - Markets Insider
Quanterix Agrees to Buy Life Sciences Firm Akoya Biosciences - MSN
AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc.AKYA - Business Wire
Quanterix Is Close to All-Stock Deal for Akoya Bioscience - MSN
Akoya climbs after merger deal with Quanterix - MSN
Shareholder Alert: Ademi LLP Investigates Whether Akoya Biosciences, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire
AKYA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akoya Biosciences, Inc. Is Fair to Shareholders - Business Wire
Quanterix to acquire Akoya Biosciences in an all-stock transaction - TipRanks
Akoya stock climbs after Quanterix merger deal (AKYA:NASDAQ) - Seeking Alpha
Major Player in the Spatial Proteomics Market 20252032 - openPR
Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers - Business Wire
A Data-Based Look At Akoya Biosciences Inc (AKYA) - Stocks Register
State Street Corp Boosts Position in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Short Interest in Akoya Biosciences, Inc. (NASDAQ:AKYA) Grows By 20.7% - Defense World
Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Rating of “Hold” by Analysts - Defense World
Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 20.7% in December - MarketBeat
Akoya Biosciences, Inc. (NASDAQ:AKYA) Shares Sold by HighTower Advisors LLC - Defense World
Charles Schwab Investment Management Inc. Decreases Stake in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Akoya Biosciences updates director and officer indemnification agreements By Investing.com - Investing.com Canada
Akoya Biosciences updates director and officer indemnification agreements - Investing.com India
Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 18.1% in November - Defense World
Market Cool On Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Revenues Pushing Shares 29% Lower - Simply Wall St
Short Interest in Akoya Biosciences, Inc. (NASDAQ:AKYA) Expands By 18.1% - MarketBeat
Akoya Biosciences and NeraCare Enter into an Exclusive - GlobeNewswire
Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions - Marketscreener.com
Nature Methods Names Spatial Proteomics 'Method of the Year 2024'Akoya Biosciences Celebrates Industry Milestone - The Manila Times
Nature Methods Names Spatial Proteomics "Method of the Year - GlobeNewswire
Akoya's Spatial Proteomics Tech Crowned 'Method of the Year 2024' by Nature Methods - StockTitan
Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone - Yahoo Finance
Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Akoya Biosciences' SWOT analysis: spatial proteomics firm faces headwinds - Investing.com India
Akoya Biosciences Inc Stock (AKYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):